2-84588891-A-G

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_001370.2(DNAH6):​c.2547A>G​(p.Gln849Gln) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0404 in 1,550,324 control chromosomes in the GnomAD database, including 3,985 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.10 ( 1846 hom., cov: 32)
Exomes 𝑓: 0.034 ( 2139 hom. )

Consequence

DNAH6
NM_001370.2 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: -0.318

Publications

10 publications found
Variant links:
Genes affected
DNAH6 (HGNC:2951): (dynein axonemal heavy chain 6) This gene belongs to the dynein family, whose members encode large proteins that are constituents of the microtubule-associated motor protein complex. This complex is composed of dynein heavy, intermediate and light chains, which can be axonemal or cytoplasmic. This protein is an axonemal dynein heavy chain. It is involved in producing force for ciliary beating by using energy from ATP hydrolysis. Mutations in this gene may cause primary ciliary dyskinesia (PCD) as well as heterotaxy. [provided by RefSeq, Jun 2016]
DNAH6 Gene-Disease associations (from GenCC):
  • male infertility with azoospermia or oligozoospermia due to single gene mutation
    Inheritance: AR Classification: MODERATE Submitted by: King Faisal Specialist Hospital and Research Center

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.94).
BP6
Variant 2-84588891-A-G is Benign according to our data. Variant chr2-84588891-A-G is described in ClinVar as [Benign]. Clinvar id is 402735.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.318 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.287 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
DNAH6NM_001370.2 linkc.2547A>G p.Gln849Gln synonymous_variant Exon 16 of 77 ENST00000389394.8 NP_001361.1 Q9C0G6-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
DNAH6ENST00000389394.8 linkc.2547A>G p.Gln849Gln synonymous_variant Exon 16 of 77 5 NM_001370.2 ENSP00000374045.3 Q9C0G6-1

Frequencies

GnomAD3 genomes
AF:
0.103
AC:
15688
AN:
152144
Hom.:
1845
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.291
Gnomad AMI
AF:
0.0154
Gnomad AMR
AF:
0.0686
Gnomad ASJ
AF:
0.0481
Gnomad EAS
AF:
0.0114
Gnomad SAS
AF:
0.0602
Gnomad FIN
AF:
0.0103
Gnomad MID
AF:
0.127
Gnomad NFE
AF:
0.0248
Gnomad OTH
AF:
0.0985
GnomAD2 exomes
AF:
0.0456
AC:
7154
AN:
156774
AF XY:
0.0443
show subpopulations
Gnomad AFR exome
AF:
0.293
Gnomad AMR exome
AF:
0.0399
Gnomad ASJ exome
AF:
0.0524
Gnomad EAS exome
AF:
0.00937
Gnomad FIN exome
AF:
0.00977
Gnomad NFE exome
AF:
0.0257
Gnomad OTH exome
AF:
0.0424
GnomAD4 exome
AF:
0.0335
AC:
46890
AN:
1398062
Hom.:
2139
Cov.:
30
AF XY:
0.0341
AC XY:
23542
AN XY:
689544
show subpopulations
African (AFR)
AF:
0.293
AC:
9214
AN:
31460
American (AMR)
AF:
0.0440
AC:
1563
AN:
35562
Ashkenazi Jewish (ASJ)
AF:
0.0518
AC:
1301
AN:
25120
East Asian (EAS)
AF:
0.0210
AC:
746
AN:
35592
South Asian (SAS)
AF:
0.0626
AC:
4942
AN:
78998
European-Finnish (FIN)
AF:
0.00859
AC:
424
AN:
49348
Middle Eastern (MID)
AF:
0.0874
AC:
497
AN:
5688
European-Non Finnish (NFE)
AF:
0.0235
AC:
25289
AN:
1078292
Other (OTH)
AF:
0.0502
AC:
2914
AN:
58002
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.478
Heterozygous variant carriers
0
1968
3936
5905
7873
9841
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1124
2248
3372
4496
5620
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.103
AC:
15705
AN:
152262
Hom.:
1846
Cov.:
32
AF XY:
0.0998
AC XY:
7431
AN XY:
74462
show subpopulations
African (AFR)
AF:
0.291
AC:
12088
AN:
41526
American (AMR)
AF:
0.0685
AC:
1048
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
0.0481
AC:
167
AN:
3470
East Asian (EAS)
AF:
0.0114
AC:
59
AN:
5186
South Asian (SAS)
AF:
0.0601
AC:
290
AN:
4828
European-Finnish (FIN)
AF:
0.0103
AC:
109
AN:
10618
Middle Eastern (MID)
AF:
0.122
AC:
36
AN:
294
European-Non Finnish (NFE)
AF:
0.0248
AC:
1685
AN:
68024
Other (OTH)
AF:
0.0989
AC:
209
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
602
1204
1805
2407
3009
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
154
308
462
616
770
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0607
Hom.:
541
Bravo
AF:
0.114
Asia WGS
AF:
0.0540
AC:
188
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

May 04, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
Mar 28, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency -

DNAH6-related disorder Benign:1
Nov 25, 2019
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.94
CADD
Benign
0.18
DANN
Benign
0.16
PhyloP100
-0.32
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1006244; hg19: chr2-84816015; COSMIC: COSV52862176; COSMIC: COSV52862176; API